High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia.

Karimi, Mohsen; Nilsson, Christer; Dimitriou, Marios; Jansson, Monika; Matsson, Hans; Unneberg, Per; Lehmann, Sören; Kere, Juha; Hellström-Lindberg, Eva

Karimi, Mohsen; Nilsson, Christer; Dimitriou, Marios; Jansson, Monika; Matsson, Hans; Unneberg, Per; Lehmann, Sören; Kere, Juha; Hellström-Lindberg, Eva.

Afiliación

Karimi M; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden.
Nilsson C; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden.
Dimitriou M; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden.
Jansson M; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden.
Matsson H; Department of Biosciences and Nutrition and Center for Innovative (CIMED), Karolinska Institutet, Sweden.
Unneberg P; Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm, Sweden.
Lehmann S; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden.
Kere J; Department of Biosciences and Nutrition and Center for Innovative (CIMED), Karolinska Institutet, Sweden Molecular Neurology Research Program, University of Helsinki and Folkhälsan Institute of Genetics, Helsinki, Finland.
Hellström-Lindberg E; Center for Hematology and Regenerative Medicine, Department of Medicine Huddinge, Karolinska Institutet, Sweden Eva.Hellstrom-Lindberg@ki.se.

Haematologica ; 100(6): e223-5, 2015 Jun.

Article en En | MEDLINE | ID: mdl-25769547

Asunto(s)

Pruebas Genéticas/métodos; Ensayos Analíticos de Alto Rendimiento/métodos; Leucemia Mieloide Aguda/genética; Mutación/genética; Síndromes Mielodisplásicos/genética; Neoplasias Primarias Secundarias/genética; Adulto; Anciano; Anciano de 80 o más Años; Células Cultivadas; Estudios de Cohortes; Femenino; Humanos; Leucemia Mieloide Aguda/diagnóstico; Leucemia Mieloide Aguda/mortalidad; Masculino; Persona de Mediana Edad; Síndromes Mielodisplásicos/diagnóstico; Síndromes Mielodisplásicos/mortalidad; Neoplasias Primarias Secundarias/diagnóstico; Sistema de Registros; Tasa de Supervivencia/tendencias

Palabras clave

acute myeloid leukemia; high-throughput mutational screening; myelodysplastic syndromes; secondary; therapy-related

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Pruebas Genéticas / Neoplasias Primarias Secundarias / Ensayos Analíticos de Alto Rendimiento / Mutación Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2015 Tipo del documento: Article País de afiliación: Suecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google